France's Cytoo Raises $4.7M to Grow High-Content Cell Analysis Business | GenomeWeb

NEW YORK (GenomeWeb News) – French high-content screening shop Cytoo said today that it has raised $4.7 million in a second funding round.

Cytoo, based in Grenoble, said that it will use the proceeds to grow its business internationally, and to expand its team and R&D efforts around its high-content cell-based screening tools for the life science research market.

New investor Auriga Partners led the financing, while existing investor Jacques Lewiner, the company's co-founder and supervisory board president, also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.